Effect of Vitamin C Infusion on Organ Failure and Biomarkers of Inflammation and Vascular Injury in Patients With Sepsis and Severe Acute Respiratory Failure
Top Cited Papers
Open Access
- 1 October 2019
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 322 (13), 1261-1270
- https://doi.org/10.1001/jama.2019.11825
Abstract
Acute respiratory distress syndrome (ARDS) is a common sepsis-associated organ injury and results in significant mortality1-4; for instance, the LUNG SAFE study reported 34% to 45% mortality.5 Despite advances in understanding mechanisms that lead to ARDS,6 disease-modifying strategies have not improved outcomes.7-12 Previous research found that vitamin C attenuates systemic inflammation, corrects sepsis-induced coagulopathy, and attenuates vascular injury.13-15 The CITRIS-ALI randomized trial examined whether high-dose vitamin C would reduce organ failure and biomarkers of inflammation and vascular injury in patients with sepsis and ARDS.Keywords
This publication has 29 references indexed in Scilit:
- Vitamin C: A Novel Regulator of Neutrophil Extracellular Trap FormationNutrients, 2013
- The Berlin definition of ARDS: an expanded rationale, justification, and supplementary materialIntensive Care Medicine, 2012
- Mechanisms of attenuation of abdominal sepsis induced acute lung injury by ascorbic acidAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2012
- Ascorbic acid attenuates lipopolysaccharide-induced acute lung injury*Critical Care Medicine, 2011
- Recent trends in acute lung injury mortality: 1996–2005*Critical Care Medicine, 2009
- Use of the Sequential Organ Failure Assessment score as a severity scoreIntensive Care Medicine, 2005
- Incidence, clinical course, and outcome in 217 patients with acute respiratory distress syndromeCritical Care Medicine, 2002
- Ventilation with Lower Tidal Volumes as Compared with Traditional Tidal Volumes for Acute Lung Injury and the Acute Respiratory Distress SyndromeThe New England Journal of Medicine, 2000
- Prevalence, etiologies and outcome of the acute respiratory distress syndrome among hypoxemic ventilated patientsIntensive Care Medicine, 1999
- Assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibody-fragment, MAK 195F, in patients with sepsis and septic shockCritical Care Medicine, 1996